Ultragenyx Pharma (RARE) PT Lowered to $47 at Wedbush
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 16.63 +0.33 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.30 | 52 Week High | $117.12 | |||
| Open | $16.52 | 52 Week Low | $46.52 | |||
| Day High | $16.99 | P/E | N/A | |||
| Day Low | $16.38 | EPS | $-1.97 | |||
| Volume | 3,708,201 | |||||
